Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Ca-A Cancer Journal for Clinicians - Tập 68 Số 6 - Trang 394-424 - 2018
Freddie Bray1, Jacques Ferlay2, Isabelle Soerjomataram3, Rebecca L. Siegel4, Lindsey A. Torre5, Ahmedin Jemal6
1Head, Section of Cancer Surveillance International Agency for Research on Cancer Lyon France
2Informatics Officer, Section of Cancer Surveillance International Agency for Research on Cancer Lyon France
3Deputy Head, Section of Cancer Surveillance, International Agency for Research on Cancer Lyon France
4Scientific Director Surveillance and Health Services Research, American Cancer Society Atlanta GA
5Scientist, Surveillance and Health Services Research, American Cancer Society Atlanta GA
6Scientific Vice President Surveillance and Health Services Research, American Cancer Society Atlanta GA

Tóm tắt

Abstract

This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality. Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality). Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality. The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors. It is noteworthy that high‐quality cancer registry data, the basis for planning and implementing evidence‐based cancer control programs, are not available in most low‐ and middle‐income countries. The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts. CA: A Cancer Journal for Clinicians 2018;0:1‐31. © 2018 American Cancer Society

Từ khóa


Tài liệu tham khảo

World Health Organization.Global Health Observatory.Geneva:World Health Organization;2018.who.int/gho/database/en/. Accessed June 21 2018.

10.2307/3349375

10.4054/DemRes.2002.7.5

Bray F, 2014, World Cancer Report 2014, 42

10.1016/S1470-2045(12)70268-1

FerlayJ ColombetM SoerjomataramIet al.Global and Regional Estimates of the Incidence and Mortality for 38 Cancers: GLOBOCAN 2018.Lyon:International Agency for Research on Cancer/World Health Organization;2018.

10.3322/canjclin.55.2.74

10.3322/caac.20107

10.3322/caac.21262

10.18356/e525b80e-en

10.1093/jnci/91.12.1017

10.1056/NEJMp1604412

BrayF ColombetM MeryLet al.Cancer Incidence in Five Continents Vol. XI (electronic version).Lyon:International Agency for Research on Cancer;2017.ci5.iarc.fr/Default.aspx. Accessed June 21 2018.

10.1007/978-3-642-85849-9

10.1016/S0959-8049(01)00267-2

10.1016/j.canep.2018.04.012

10.1016/j.ejca.2013.10.014

Thun MJ, 2018, Cancer Epidemiology and Prevention, 519

10.1056/NEJMoa1715907

10.1038/nrc2703

10.1158/1055-9965.EPI-14-0281

FerlayJ BrayF Steliarova‐FoucherE FormanD.Cancer Incidence in Five Continents CI5plus. IARC CancerBase No. 9.Lyon:International Agency for Research on Cancer;2018.ci5.iarc.fr/CI5plus/default.aspx. Accessed June 21 2018.

10.1093/jnci/85.22.1819

Brinton LA, 2018, Cancer Epidemiology and Prevention, 861

10.1186/bcr932

10.1001/jama.288.3.321

10.1056/NEJMsr070105

10.1002/ijc.30382

10.1136/gutjnl-2015-310912

10.1136/gutjnl-2014-309086

Wu K, 2018, Cancer Epidemiology and Prevention, 681

World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR).Continuous Update Project Report: Diet Nutrition Physical Activity and Colorectal Cancer 2016. Revised 2018.London:World Cancer Research Fund International;2018.aicr.org/continuous-update-project/reports/colorectal-cancer-2017-report.pdf. Accessed June 21 2018.

10.1097/CEJ.0b013e3283472241

10.1155/2013/560857

10.1007/978-3-319-42769-0_1

10.1093/jnci/djm249

10.1002/ijc.29894

10.1016/j.eururo.2012.02.054

10.1001/jama.2018.3710

10.1002/ijc.30924

10.21149/spm.v58i2.7779

10.1002/ijc.28661

10.1002/ijc.28063

10.1016/j.eururo.2016.05.043

10.1093/jncimonographs/lgs035

Kolonel LN, 1986, Diet, Nutrition and Cancer. Proceedings of the 16th International Symposium of the Princess Takamatsu Cancer Research Fund; Tokyo, Japan; 1985, 29

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1994, Infection with Helicobacter pylori, IARC Monogr Eval Carcinog Risks Hum., 61, 177

10.1002/ijc.28999

World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR).Continuous Update Project Report: Diet Nutrition Physical Activity and Stomach Cancer 2016. Revised 2018.London:World Cancer Research Fund International;2018.wcrf.org/sites/default/files/Stomach-Cancer-2016-Report.pdf. Accessed June 21 2018.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, Personal habits and indoor combustions. Volume 100 E. A review of human carcinogens, IARC Monogr Eval Carcinog Risks Hum., 100, 1

10.1093/oxfordjournals.epirev.a036288

deMartel C, 2018, Cancer Epidemiology and Prevention, 593

London WT, 2018, Cancer Epidemiology and Prevention, 635

10.1002/ijc.30463

10.1146/annurev-med-090514-013832

World Health Organization.Global Health Observatory (GHO) data: Hepatitis B 3rd Dose (HepB3) Immunization Coverage.Geneva:World Health Organization;2017.who.int/gho/immunization/hepatitis/en/. Accessed February 27 2018.

10.1056/NEJM199706263362602

10.1038/nrgastro.2013.179

Blot WJ, 2018, Cancer Epidemiology and Prevention, 579

10.1002/ijc.30292

10.1038/ajg.2017.155

10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, Human papillomaviruses, IARC Monogr Eval Carcinog Risks Hum., 90, 1

Herrero R, 2018, Cancer Epidemiology and Prevention, 925

International Agency for Research on Cancer (IARC).IARC Handbooks of Cancer Prevention: Volume 10‐Cervix Cancer Screening.Lyon:IARC Press; 2005.iarc.fr/en/publications/pdfs-online/prev/handbook10/HANDBOOK10.pdf. Accessed June 21 2018.

10.1158/1055-9965.EPI-05-0231

10.1158/1055-9965.EPI-04-0569

10.1016/j.vaccine.2013.02.071

10.1002/ijc.30901

10.1016/S0140-6736(13)62218-7

10.1016/j.ijgo.2015.02.014

Thun MJ, 2018, Cancer Epidemiology and Prevention, 1193

10.1038/nrclinonc.2015.146

Kitahara CM, 2018, Cancer Epidemiology and Prevention, 839

Silverman DT, 2018, Cancer Epidemiology and Prevention, 977

10.1001/jama.2011.1142

10.3322/caac.21440

10.1080/0284186X.2016.1197419

10.1002/ijc.31088

10.1038/s41416-018-0029-6

10.1093/epirev/mxx003

10.1007/s10147-008-0762-6

10.1016/S0140-6736(15)00135-X

Thông tin
Thông tin xuất bản

Ca-A Cancer Journal for Clinicians

Tập 68 Số 6

394-424

Thông tin tác giả